More MS patients remain free from disease activity with teriflunomide versus placebo in temso, a phase III trial

Authors
Category Primary study
ConferenceAnnals of Neurology
Year 2012
This article has no abstract
Epistemonikos ID: b7e74f587b0a2e590d0f9bc45a6a13544a256676
First added on: Apr 30, 2026